-
1
-
-
0035253701
-
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center Experience
-
Brito RA, Valero V, Buzdar AU, et al.: Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M.D. Anderson Cancer Center Experience. J Clin Oncol 2001, 19:628-633.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 628-633
-
-
Brito, R.A.1
Valero, V.2
Buzdar, A.U.3
-
2
-
-
0026741580
-
Treatment of locally advanced breast cancer
-
Booser DJ, Hortobagyi GN: Treatment of locally advanced breast cancer. Semin Oncol 1992, 19:278-285.
-
(1992)
Semin. Oncol.
, vol.19
, pp. 278-285
-
-
Booser, D.J.1
Hortobagyi, G.N.2
-
3
-
-
0034034257
-
Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques
-
Smith BM, Slade MJ, English J, et al.: Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol 2000, 18:1432-1439.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 1432-1439
-
-
Smith, B.M.1
Slade, M.J.2
English, J.3
-
4
-
-
0033996457
-
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
-
Braun S, Pantel K, Muller P, et al.: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000, 342:525-533.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 525-533
-
-
Braun, S.1
Pantel, K.2
Muller, P.3
-
6
-
-
0032713821
-
Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin
-
Abolhoda A, Wilson AE, Ross H, et al.: Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res 1999, 5:3352-3356.
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 3352-3356
-
-
Abolhoda, A.1
Wilson, A.E.2
Ross, H.3
-
7
-
-
0033986270
-
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
-
Braun S, Kentenich C, Janni W, et al.: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 2000, 18:80-86.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 80-86
-
-
Braun, S.1
Kentenich, C.2
Janni, W.3
-
8
-
-
0034901095
-
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy
-
Kasimir-Bauer S, Mayer S, Bojko P, et al.: Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy. Clin Cancer Res 2001, 7:1582-1589.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 1582-1589
-
-
Kasimir-Bauer, S.1
Mayer, S.2
Bojko, P.3
-
10
-
-
0031926839
-
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
-
Fisher B, Bryant J, Wolmark N, et al.: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16:2672-2685.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 2672-2685
-
-
Fisher, B.1
Bryant, J.2
Wolmark, N.3
-
11
-
-
0028941377
-
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
-
Powles TJ, Hickish TF, Makris A, et al.: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995, 13:547-552.
-
(1995)
J. Clin. Oncol.
, vol.13
, pp. 547-552
-
-
Powles, T.J.1
Hickish, T.F.2
Makris, A.3
-
12
-
-
0035890633
-
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
-
van der Hage JA, van de Velde CJ, Julien JP, et al.: Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001, 19:4224-4237.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 4224-4237
-
-
van der Hage, J.A.1
van de Velde, C.J.2
Julien, J.P.3
-
13
-
-
0024600538
-
Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy: An EORTC Breast Cancer Cooperative Group Trial (10792)
-
Rubens RD, Bartelink H, Engelsman E, et al.: Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy: an EORTC Breast Cancer Cooperative Group Trial (10792). Eur J Cancer Clin Oncol 1989, 25:667-678.
-
(1989)
Eur. J. Cancer Clin. Oncol.
, vol.25
, pp. 667-678
-
-
Rubens, R.D.1
Bartelink, H.2
Engelsman, E.3
-
14
-
-
0025980221
-
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)
-
Gazet JC, Ford HT, Coombes RC: Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study). Br J Cancer 1991, 63:279-282.
-
(1991)
Br. J. Cancer
, vol.63
, pp. 279-282
-
-
Gazet, J.C.1
Ford, H.T.2
Coombes, R.C.3
-
15
-
-
0027155354
-
Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis
-
Attia-Sobol J, Ferriere JP, Cure H, et al.: Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis. Eur J Cancer 1993, 29A:1081-1088.
-
(1993)
Eur. J. Cancer
, vol.29 A
, pp. 1081-1088
-
-
Attia-Sobol, J.1
Ferriere, J.P.2
Cure, H.3
-
16
-
-
0027409344
-
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients
-
Chevallier B, Bastit P, Graic Y, et al.: The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients. Br J Cancer 1993, 67:594-601.
-
(1993)
Br. J. Cancer
, vol.67
, pp. 594-601
-
-
Chevallier, B.1
Bastit, P.2
Graic, Y.3
-
17
-
-
0032168519
-
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: Prognostic and therapeutic implications
-
Karlsson YA, Malmstrom PO, Hatschek T, et al.: Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications. Cancer 1998, 83:936-947.
-
(1998)
Cancer
, vol.83
, pp. 936-947
-
-
Karlsson, Y.A.1
Malmstrom, P.O.2
Hatschek, T.3
-
18
-
-
0022860622
-
Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy
-
Rouesse J, Friedman S, Sarrazin D, et al.: Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 1986, 4:1765-1771.
-
(1986)
J. Clin. Oncol.
, vol.4
, pp. 1765-1771
-
-
Rouesse, J.1
Friedman, S.2
Sarrazin, D.3
-
19
-
-
0032946705
-
Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer
-
Honkoop AH, Luykx-de Bakker SA, Hoekman K, et al.: Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer. Oncologist 1999, 4:106-111.
-
(1999)
Oncologist
, vol.4
, pp. 106-111
-
-
Honkoop, A.H.1
Luykx-de Bakker, S.A.2
Hoekman, K.3
-
20
-
-
0036643778
-
Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF
-
LeBedis C, Chen K, Fallavollita L, et al.: Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002, 100:2-8.
-
(2002)
Int. J. Cancer
, vol.100
, pp. 2-8
-
-
LeBedis, C.1
Chen, K.2
Fallavollita, L.3
-
21
-
-
0028144438
-
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer
-
Disis ML, Calenoff E, McLaughlin G, et al.: Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 1994, 54:16-20.
-
(1994)
Cancer Res.
, vol.54
, pp. 16-20
-
-
Disis, M.L.1
Calenoff, E.2
McLaughlin, G.3
-
22
-
-
0030033054
-
Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer
-
Schlom J, Kantor J, Abrams S, et al.: Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer. Breast Cancer Res Treat 1996, 38:27-39.
-
(1996)
Breast Cancer Res. Treat.
, vol.38
, pp. 27-39
-
-
Schlom, J.1
Kantor, J.2
Abrams, S.3
-
23
-
-
0025109257
-
Immunohistological distribution of 5T4 antigen in normal and malignant tissues
-
Southall PJ, Boxer GM, Bagshawe KD, et al.: Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 1990, 61:89-95.
-
(1990)
Br. J. Cancer
, vol.61
, pp. 89-95
-
-
Southall, P.J.1
Boxer, G.M.2
Bagshawe, K.D.3
-
24
-
-
17344392248
-
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
-
von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, et al.: Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 2000, 18:574-583.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 574-583
-
-
von Mensdorff-Pouilly, S.1
Verstraeten, A.A.2
Kenemans, P.3
-
25
-
-
0030934973
-
Decreased antigen presentation by dendritic cells in patients with breast cancer
-
Gabrilovich DI, Corak J, Ciernik IF, et al.: Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997, 3:483-490.
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 483-490
-
-
Gabrilovich, D.I.1
Corak, J.2
Ciernik, I.F.3
-
26
-
-
0032546352
-
Dendritic cells and the control of immunity
-
Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
-
(1998)
Nature
, vol.392
, pp. 245-252
-
-
Banchereau, J.1
Steinman, R.M.2
-
28
-
-
0030896205
-
Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines
-
Mayordomo JI, Zorina T, Storkus WJ, et al.: Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells 1997, 15:94-103.
-
(1997)
Stem Cells
, vol.15
, pp. 94-103
-
-
Mayordomo, J.I.1
Zorina, T.2
Storkus, W.J.3
-
29
-
-
0031896891
-
Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma
-
Coppola D, Fu L, Nicosia SV, et al.: Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma. Hum Pathol 1998, 29:455-462.
-
(1998)
Hum. Pathol.
, vol.29
, pp. 455-462
-
-
Coppola, D.1
Fu, L.2
Nicosia, S.V.3
-
30
-
-
0025816551
-
Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance
-
Gallo O, Bianchi S, Giannini A, et al.: Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope 1991, 101:487-493.
-
(1991)
Laryngoscope
, vol.101
, pp. 487-493
-
-
Gallo, O.1
Bianchi, S.2
Giannini, A.3
-
31
-
-
0031827465
-
Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma
-
Ikeguchi M, Ikeda M, Tatebe S, et al.: Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma. Oncol Rep 1998, 5:1185-1189.
-
(1998)
Oncol. Rep.
, vol.5
, pp. 1185-1189
-
-
Ikeguchi, M.1
Ikeda, M.2
Tatebe, S.3
-
32
-
-
0030711097
-
Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer
-
Ishigami S, Aikou T, Natsugoe S, et al.: Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998, 55:65-69.
-
(1998)
Oncology
, vol.55
, pp. 65-69
-
-
Ishigami, S.1
Aikou, T.2
Natsugoe, S.3
-
33
-
-
0031738664
-
Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue
-
Saito H, Tsujitani S, Ikeguchi M, et al.: Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 1998, 78:1573-1577.
-
(1998)
Br. J. Cancer
, vol.78
, pp. 1573-1577
-
-
Saito, H.1
Tsujitani, S.2
Ikeguchi, M.3
-
34
-
-
0037448353
-
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
-
Zhang L, Conejo-Garcia JR, Katsaros D, et al.: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003, 348:203-213.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 203-213
-
-
Zhang, L.1
Conejo-Garcia, J.R.2
Katsaros, D.3
-
35
-
-
0033571785
-
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
-
Bell D, Chomarat P, Broyles D, et al.: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999, 190:1417-1426.
-
(1999)
J. Exp. Med.
, vol.190
, pp. 1417-1426
-
-
Bell, D.1
Chomarat, P.2
Broyles, D.3
-
36
-
-
0033514923
-
Immune surveillance against a solid tumor fails because of immunological ignorance
-
Ochsenbein AF, Klenerman P, Karrer U, et al.: Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 1999, 96:2233-2238.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 2233-2238
-
-
Ochsenbein, A.F.1
Klenerman, P.2
Karrer, U.3
-
37
-
-
0031049941
-
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor
-
Buelens C, Verhasselt V, De Groote D, et al.: Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 1997, 27:756-762.
-
(1997)
Eur. J. Immunol.
, vol.27
, pp. 756-762
-
-
Buelens, C.1
Verhasselt, V.2
De Groote, D.3
-
38
-
-
0032400862
-
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
-
Gabrilovich D, Ishida T, Oyama T, et al.: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998, 92:4150-4166.
-
(1998)
Blood
, vol.92
, pp. 4150-4166
-
-
Gabrilovich, D.1
Ishida, T.2
Oyama, T.3
-
39
-
-
0029842830
-
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
-
Gabrilovich DI, Chen HL, Girgis KR, et al.: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 1996, 2:1096-1103.
-
(1996)
Nat. Med.
, vol.2
, pp. 1096-1103
-
-
Gabrilovich, D.I.1
Chen, H.L.2
Girgis, K.R.3
-
40
-
-
0031013905
-
Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step
-
Morel AS, Quaratino S, Douek DC, Londei M: Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol 1997, 27:26-34.
-
(1997)
Eur. J. Immunol.
, vol.27
, pp. 26-34
-
-
Morel, A.S.1
Quaratino, S.2
Douek, D.C.3
Londei, M.4
-
41
-
-
0036569357
-
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation
-
Sombroek CC, Stam AG, Masterson AJ, et al.: Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 2002, 168:4333-4343.
-
(2002)
J. Immunol.
, vol.168
, pp. 4333-4343
-
-
Sombroek, C.C.1
Stam, A.G.2
Masterson, A.J.3
-
42
-
-
0034653462
-
Tumor-induced apoptosis of T lymphocytes: Elucidation of intracellular apoptotic events
-
Gastman BR, Johnson DE, Whiteside TL, Rabinowich H: Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events. Blood 2000, 95:2015-2023.
-
(2000)
Blood
, vol.95
, pp. 2015-2023
-
-
Gastman, B.R.1
Johnson, D.E.2
Whiteside, T.L.3
Rabinowich, H.4
-
43
-
-
0030659077
-
Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma
-
Marrogi AJ, Munshi A, Merogi AJ, et al.: Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer 1997, 74:492-501.
-
(1997)
Int. J. Cancer
, vol.74
, pp. 492-501
-
-
Marrogi, A.J.1
Munshi, A.2
Merogi, A.J.3
-
44
-
-
0033060409
-
Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: A study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome
-
Lespagnard L, Gancberg D, Rouas G, et al.: Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 1999, 84:309-314.
-
(1999)
Int. J. Cancer
, vol.84
, pp. 309-314
-
-
Lespagnard, L.1
Gancberg, D.2
Rouas, G.3
-
45
-
-
0028013266
-
Local recurrences following mastectomy: Support for the concept of tumor dormancy
-
Demicheli R, Terenziani M, Valagussa P, et al.: Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 1994, 86:45-48.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 45-48
-
-
Demicheli, R.1
Terenziani, M.2
Valagussa, P.3
-
46
-
-
0028951043
-
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
-
Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1:149-153.
-
(1995)
Nat. Med.
, vol.1
, pp. 149-153
-
-
Holmgren, L.1
O'Reilly, M.S.2
Folkman, J.3
-
47
-
-
0027970092
-
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
-
O'Reilly MS, Holmgren L, Shing Y, et al.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328.
-
(1994)
Cell
, vol.79
, pp. 315-328
-
-
O'Reilly, M.S.1
Holmgren, L.2
Shing, Y.3
-
48
-
-
0031454617
-
Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
-
O'Reilly MS, Boehm T, Shing Y, et al.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
-
(1997)
Cell
, vol.88
, pp. 277-285
-
-
O'Reilly, M.S.1
Boehm, T.2
Shing, Y.3
-
49
-
-
0030576517
-
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
-
Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
-
(1996)
Cell
, vol.86
, pp. 353-364
-
-
Hanahan, D.1
Folkman, J.2
-
50
-
-
0032544686
-
Tumor induction of VEGF promoter activity in stromal cells
-
Fukumura D, Xavier R, Sugiura T, et al.: Tumor induction of VEGF promoter activity in stromal cells. Cell 1998, 94:715-725.
-
(1998)
Cell
, vol.94
, pp. 715-725
-
-
Fukumura, D.1
Xavier, R.2
Sugiura, T.3
-
51
-
-
0032576346
-
Involvement of platelets in tumour angiogenesis?
-
Pinedo HM, Verheul HM, D'Amato RJ, Folkman J: Involvement of platelets in tumour angiogenesis? Lancet 1998, 352:1775-1777.
-
(1998)
Lancet
, vol.352
, pp. 1775-1777
-
-
Pinedo, H.M.1
Verheul, H.M.2
D'Amato, R.J.3
Folkman, J.4
-
52
-
-
0021684729
-
Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages
-
Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984, 51:635-642.
-
(1984)
Lab. Invest.
, vol.51
, pp. 635-642
-
-
Polverini, P.J.1
Leibovich, S.J.2
-
53
-
-
0025147371
-
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
-
Good DJ, Polverini PJ, Rastinejad F, et al.: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 1990, 87:6624-6628.
-
(1990)
Proc. Natl. Acad. Sci. U. S. A.
, vol.87
, pp. 6624-6628
-
-
Good, D.J.1
Polverini, P.J.2
Rastinejad, F.3
-
54
-
-
0022252997
-
Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth
-
Homandberg GA, Williams JE, Grant D, et al.: Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am J Pathol 1985, 120:327-332.
-
(1985)
Am. J. Pathol.
, vol.120
, pp. 327-332
-
-
Homandberg, G.A.1
Williams, J.E.2
Grant, D.3
-
55
-
-
0032582635
-
Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells
-
Lee TH, Rhim T, Kim SS: Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells. J Biol Chem 1998, 273:28805-28812.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 28805-28812
-
-
Lee, T.H.1
Rhim, T.2
Kim, S.S.3
-
56
-
-
0031454617
-
Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
-
O'Reilly MS, Boehm T, Shing Y, et al.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
-
(1997)
Cell
, vol.88
, pp. 277-285
-
-
O'Reilly, M.S.1
Boehm, T.2
Shing, Y.3
-
57
-
-
15644374164
-
Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers
-
Morelli D, Lazzerini D, Cazzaniga S, et al.: Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers. Clin Cancer Res 1998, 4:1221-1225.
-
(1998)
Clin. Cancer Res.
, vol.4
, pp. 1221-1225
-
-
Morelli, D.1
Lazzerini, D.2
Cazzaniga, S.3
-
59
-
-
0033968571
-
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas
-
Verheul HM, Hoekman K, Lupu F, et al.: Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 2000, 6:166-71.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 166-171
-
-
Verheul, H.M.1
Hoekman, K.2
Lupu, F.3
-
60
-
-
0034672373
-
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets
-
Verheul HM, Jorna AS, Hoekman K, et al.: Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 2000, 96:4216-4221.
-
(2000)
Blood
, vol.96
, pp. 4216-4221
-
-
Verheul, H.M.1
Jorna, A.S.2
Hoekman, K.3
-
61
-
-
0032483682
-
Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents
-
Joseph IB, Isaacs JT: Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J Natl Cancer Inst 1998, 90:1648-1653.
-
(1998)
J. Natl. Cancer Inst.
, vol.90
, pp. 1648-1653
-
-
Joseph, I.B.1
Isaacs, J.T.2
-
62
-
-
0030998660
-
Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
-
Dong Z, Kumar R, Yang X, Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997, 88:801-810.
-
(1997)
Cell
, vol.88
, pp. 801-810
-
-
Dong, Z.1
Kumar, R.2
Yang, X.3
Fidler, I.J.4
-
63
-
-
0032541472
-
Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor
-
Dong Z, Yoneda J, Kumar R, Fidler IJ: Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor. J Exp Med 1998, 188:755-763.
-
(1998)
J. Exp. Med.
, vol.188
, pp. 755-763
-
-
Dong, Z.1
Yoneda, J.2
Kumar, R.3
Fidler, I.J.4
-
64
-
-
0031036948
-
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer
-
Honkoop AH, Pinedo HM, de Jong JS, et al.: Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 1997, 107:211-218.
-
(1997)
Am. J. Clin. Pathol.
, vol.107
, pp. 211-218
-
-
Honkoop, A.H.1
Pinedo, H.M.2
de Jong, J.S.3
-
65
-
-
0032485487
-
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
-
Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86-89.
-
(1998)
Nature
, vol.392
, pp. 86-89
-
-
Albert, M.L.1
Sauter, B.2
Bhardwaj, N.3
-
66
-
-
0031798137
-
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
-
Inaba K, Turley S, Yamaide F, et al.: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998, 188:2163-2173.
-
(1998)
J. Exp. Med.
, vol.188
, pp. 2163-2173
-
-
Inaba, K.1
Turley, S.2
Yamaide, F.3
-
67
-
-
0034614886
-
The induction of tolerance by dendritic cells that have captured apoptotic cells
-
Steinman RM, Turley S, Mellman I, Inaba K: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000, 191:411-416.
-
(2000)
J. Exp. Med.
, vol.191
, pp. 411-416
-
-
Steinman, R.M.1
Turley, S.2
Mellman, I.3
Inaba, K.4
-
68
-
-
0032695108
-
Natural adjuvants: Endogenous activators of dendritic cells
-
Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
-
(1999)
Nat. Med.
, vol.5
, pp. 1249-1255
-
-
Gallucci, S.1
Lolkema, M.2
Matzinger, P.3
-
69
-
-
0034614897
-
Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
-
Sauter B, Albert ML, Francisco L, et al.: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000, 191:423-434.
-
(2000)
J. Exp. Med.
, vol.191
, pp. 423-434
-
-
Sauter, B.1
Albert, M.L.2
Francisco, L.3
-
70
-
-
0035328683
-
Cyclophosphamide doxorubicin and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
-
Machiels JP, Reilly RT, Emens LA, et al.: Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001, 61:3689-3697.
-
(2001)
Cancer Res.
, vol.61
, pp. 3689-3697
-
-
Machiels, J.P.1
Reilly, R.T.2
Emens, L.A.3
-
71
-
-
0023203184
-
A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma
-
Carmo-Pereira J, Costa FO, Henriques E, et al.: A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma. Br J Cancer 1987, 56:471-473
-
(1987)
Br. J. Cancer
, vol.56
, pp. 471-473
-
-
Carmo-Pereira, J.1
Costa, F.O.2
Henriques, E.3
-
72
-
-
0023798680
-
Preclinical studies and clinical correlation of the effect of alkylating dose
-
Frei E III, Teicher BA, Holden SA, et al.: Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res 1988, 48:6417-6423.
-
(1988)
Cancer Res.
, vol.48
, pp. 6417-6423
-
-
Frei III, E.1
Teicher, B.A.2
Holden, S.A.3
-
73
-
-
0030032778
-
Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients
-
Honkoop AH, Hoekman K, Wagstaff J, et al.: Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients. Ann Oncol 1996, 7:35-39.
-
(1996)
Ann. Oncol.
, vol.7
, pp. 35-39
-
-
Honkoop, A.H.1
Hoekman, K.2
Wagstaff, J.3
-
74
-
-
0021744793
-
The importance of dose intensity in chemotherapy of metastatic breast cancer
-
Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984, 2:1281-1288.
-
(1984)
J. Clin. Oncol.
, vol.2
, pp. 1281-1288
-
-
Hryniuk, W.1
Bush, H.2
-
75
-
-
0023127989
-
A phase I-II study of intensive-dose adriamycin for advanced breast cancer
-
Jones RB, Holland JF, Bhardwaj S, et al.: A phase I-II study of intensive-dose adriamycin for advanced breast cancer. J Clin Oncol 1987, 5:172-177.
-
(1987)
J. Clin. Oncol.
, vol.5
, pp. 172-177
-
-
Jones, R.B.1
Holland, J.F.2
Bhardwaj, S.3
-
76
-
-
0026000905
-
Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer
-
Hoekman K, Wagstaff J, van Groeningen CJ, et al.: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer. J Natl Cancer Inst 1991, 83:1546-1553.
-
(1991)
J. Natl. Cancer Inst.
, vol.83
, pp. 1546-1553
-
-
Hoekman, K.1
Wagstaff, J.2
van Groeningen, C.J.3
-
77
-
-
0033061169
-
Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerations
-
Luykx-de Bakker SA, Verheul HM, de Gruijl TD, Pinedo HM: Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerations. Ann Oncol 1999, 10:155-160.
-
(1999)
Ann. Oncol.
, vol.10
, pp. 155-160
-
-
Luykx-de Bakker, S.A.1
Verheul, H.M.2
de Gruijl, T.D.3
Pinedo, H.M.4
|